| Drug Name |
Iopromide |
| Drug ID |
BADD_D01182 |
| Description |
Iopromide is a low osmolar, non-ionic X-ray contrast agent for intravascular administration. It functions as a contrast agent by opacifying blood vessels in the path of flow of the contrast agent, permitting radiographic visualization of the internal structures until significant hemodilution occurs.
Available as the FDA-approved product Ultravist, iopromide is used in radiographic studies such as intra-arterial digital subtraction angiography (IA-DSA), cerebral and peripheral arteriography, peripheral venography, excretory urography, brain computer tomography (CT), coronary arteriography, left ventriculography, visceral angiography, and aortography. |
| Indications and Usage |
Contrast computed tomography (CT) imaging of head and body (300 mg I/mL and 370 mg I/mL) |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
V08AB05 |
| DrugBank ID |
DB09156
|
| KEGG ID |
D01893
|
| MeSH ID |
C038192
|
| PubChem ID |
3736
|
| TTD Drug ID |
D07GNP
|
| NDC Product Code |
50419-346; 50419-344 |
| Synonyms |
iopromide | lopromid | N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N-methylisophthalamide | iopromid | Ultravist 300 | Clarograf | Ultravist |
